<DOC>
	<DOCNO>NCT02645227</DOCNO>
	<brief_summary>The present study design evaluate combine efficacy Platelet Rich Fibrin ( PRF ) 1.2 % Rosuvastatin ( RSV ) open flap debridement ( OFD ) treatment intrabony defect chronic periodontitis patient</brief_summary>
	<brief_title>Platelet-rich Fibrin With 1.2 % Rosuvastatin Chronic Periodontitis Treatment</brief_title>
	<detailed_description>ABSTRACT Background : Regenerative periodontal therapy encompasses use various bioactive agent inflammo-modulatory also osteoclast-inhibitory rather , osteostimulative . The hypolipidaemic Statin group drug , particularly Rosuvastatin ( RSV ) , know associated alveolar bone formation periodontal improvement . Platelet analogue like Platelet rich fibrin ( PRF ) , rich source growth factor , also come widespread periodontal regenerative use . The aim study evaluate compare efficacy open-ﬂap debridement ( OFD ) without PRF PRF + 1.2 % RSV gel treatment intrabony defect ( IBDs ) chronic periodontitis ( CP ) patient . Methods : Ninety individual total 90 IBDs randomly assign one 3 treatment group : 1 ) OFD alone , 2 ) OFD + PRF 3 ) OFD + PRF + 1.2 % RSV gel placement . Plaque index ( PI ) , modify sulcus bleed index ( mSBI ) , probe depth ( PD ) , clinical attachment ( CA ) level IBD depth record baseline 9 month post-operatively .</detailed_description>
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Chronic Periodontitis</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Systemically healthy CP diagnosis16 probe depth ( PD ) ≥5mm , clinical attachment ( CA ) level ≥3mm vertical bone loss ≥3mm intraoral periapical radiograph ( IOPAR ) without antibiotic periodontal therapy last 6 month . History statin allergy , statin therapy , systemic condition medication alter periodontal condition , immunecompromised state , hematologic disorder , insufﬁcient platelet count ( &lt; 200,000/mm3 ) , aggressive periodontitis , substance/tobacco abuse lactate pregnant female .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>